152 related articles for article (PubMed ID: 38852250)
1. Ultrasonic treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in water: An updated review.
An S; Nam SN; Choi JS; Park CM; Jang M; Lee JY; Jun BM; Yoon Y
J Hazard Mater; 2024 Aug; 474():134852. PubMed ID: 38852250
[TBL] [Abstract][Full Text] [Related]
2. Catalytic non-thermal plasma treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in aqueous solution: A review.
Nam SN; Choong CE; Hoque S; Farouk TI; Cho J; Jang M; Snyder SA; Meadows ME; Yoon Y
Chemosphere; 2022 Mar; 290():133395. PubMed ID: 34952026
[TBL] [Abstract][Full Text] [Related]
3. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant.
Padhye LP; Yao H; Kung'u FT; Huang CH
Water Res; 2014 Mar; 51():266-76. PubMed ID: 24262763
[TBL] [Abstract][Full Text] [Related]
4. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
Esplugas S; Bila DM; Krause LG; Dezotti M
J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
[TBL] [Abstract][Full Text] [Related]
5. Prediction of adsorption capacity for pharmaceuticals, personal care products and endocrine disrupting chemicals onto various adsorbent materials.
Bunmahotama W; Lin TF; Yang X
Chemosphere; 2020 Jan; 238():124658. PubMed ID: 31548174
[TBL] [Abstract][Full Text] [Related]
6. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
[TBL] [Abstract][Full Text] [Related]
7. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
[TBL] [Abstract][Full Text] [Related]
8. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes.
Westerhoff P; Yoon Y; Snyder S; Wert E
Environ Sci Technol; 2005 Sep; 39(17):6649-63. PubMed ID: 16190224
[TBL] [Abstract][Full Text] [Related]
9. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan.
Wu Q; Shi H; Adams CD; Timmons T; Ma Y
Sci Total Environ; 2012 Nov; 439():18-25. PubMed ID: 23059968
[TBL] [Abstract][Full Text] [Related]
10. Degradations of endocrine-disrupting chemicals and pharmaceutical compounds in wastewater with carbon-based nanomaterials: a critical review.
Ojha A; Tiwary D; Oraon R; Singh P
Environ Sci Pollut Res Int; 2021 Jun; 28(24):30573-30594. PubMed ID: 33909248
[TBL] [Abstract][Full Text] [Related]
11. Transformation of endocrine disrupting chemicals, pharmaceutical and personal care products during drinking water disinfection.
Leusch FDL; Neale PA; Busetti F; Card M; Humpage A; Orbell JD; Ridgway HF; Stewart MB; van de Merwe JP; Escher BI
Sci Total Environ; 2019 Mar; 657():1480-1490. PubMed ID: 30677914
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.
Rahman MF; Yanful EK; Jasim SY
J Water Health; 2009 Jun; 7(2):224-43. PubMed ID: 19240349
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analyses for monitoring EDCs and PPCPs in a lake water.
Park M; Reckhow D; Lavine M; Rosenfeld E; Stanford B; Park MH
Water Environ Res; 2014 Nov; 86(11):2233-41. PubMed ID: 25509528
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea).
Yoon Y; Ryu J; Oh J; Choi BG; Snyder SA
Sci Total Environ; 2010 Jan; 408(3):636-43. PubMed ID: 19900699
[TBL] [Abstract][Full Text] [Related]
15. Rapid resolution liquid chromatography-tandem mass spectrometry method for the determination of endocrine disrupting chemicals (EDCs), pharmaceuticals and personal care products (PPCPs) in wastewater irrigated soils.
Chen F; Ying GG; Yang JF; Zhao JL; Wang L
J Environ Sci Health B; 2010 Oct; 45(7):682-93. PubMed ID: 20818522
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound for the degradation of endocrine disrupting compounds in aqueous solution: A review on mechanisms, influence of operating parameters and cost estimation.
Ghosh S; Sahu M
Chemosphere; 2024 Feb; 349():140864. PubMed ID: 38061558
[TBL] [Abstract][Full Text] [Related]
17. A QSAR-like analysis of the adsorption of endocrine disrupting compounds, pharmaceuticals, and personal care products on modified activated carbons.
Redding AM; Cannon FS; Snyder SA; Vanderford BJ
Water Res; 2009 Aug; 43(15):3849-61. PubMed ID: 19592065
[TBL] [Abstract][Full Text] [Related]
18. Removal of pharmaceuticals and personal care products (PPCPs) from wastewater: A review.
Wang J; Wang S
J Environ Manage; 2016 Nov; 182():620-640. PubMed ID: 27552641
[TBL] [Abstract][Full Text] [Related]
19. Sulfate radicals-based advanced oxidation processes for the degradation of pharmaceuticals and personal care products: A review on relevant activation mechanisms, performance, and perspectives.
Hassani A; Scaria J; Ghanbari F; Nidheesh PV
Environ Res; 2023 Jan; 217():114789. PubMed ID: 36375505
[TBL] [Abstract][Full Text] [Related]
20. The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental waters.
Archer E; Petrie B; Kasprzyk-Hordern B; Wolfaardt GM
Chemosphere; 2017 May; 174():437-446. PubMed ID: 28187390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
